Bioprocessing

Bioprocessing uses a complete living cell, or their components, to obtain or create a desired pharmaceutical product. Recent scientific advancements have led to biopharmaceuticals being the fastest growing drug type, leading to rapid process and equipment advances. Below you can explore editorial articles, webinars, informational resources, and products curated to keep you up to date with bioprocessing advancements.

Editorial Articles

  • Awakening the Giant: The Next Frontier in mRNA Therapeutics

    The remarkable success of messenger RNA-based vaccines during the COVID-19 pandemic has sparked widespread interest and enthusiasm around mRNA technology. But vaccines are just the beginning. Researchers and biotech innovators worldwide are rapidly uncovering the broader potential of mRNA to address a vast array of health challenges, from cancer ... read more

  • Mechanistic Modeling: Biotechnology Manufacturing

    Mechanistic modeling in biotechnology refers to the development of models based on the underlying biological, chemical, and physical processes that govern cellular behavior, enzyme kinetics, metabolic pathways, and bioreactor systems. These models are crucial in understanding and optimizing processes in biotechnology, from the design of bioreactors... read more

  • Culture Media Considerations for Compliant Aseptic Process Simulations

    Aseptic process simulation (APS) is a critical periodic test that manufacturers of aseptically filled products must conduct to verify that their process is capable of assuring product sterility. In this simulation the actual product is typically replaced with a sterile nutrient medium. An APS should closely replicate the routine aseptic ... read more

  • COVID-19 Five Years Later: The Impact on Drug Discovery

    Five years ago, COVID-19 was declared a global pandemic, marking the official onset of a healthcare crisis that has claimed more than seven million lives and whose impact continues to resonate today. Initial containment efforts for the evasive and evolving SARS-CoV-2 virus required unprecedented collaboration between nations, healthcare agencies, ... read more

  • An Interview with Lamin Jallow

    The main difference is the level of detail in the new USP 73. As a chapter with a two-digit number, it contains some methodology and details that were missing in the original publication. For instance, it contains an equation to calculate the incubation time before ATP bioluminescence detection is performed. read more

  • An Interview with Marc Studer

    Samsung Biologics has continuously invested in its capabilities to address the evolving needs of the biopharmaceutical industry. With numerous large pharmaceutical companies and emerging biotech firms introducing ADC programs given its promising therapeutic potential, the company has strategically expanded into ADC development and manufacturing to ... read more
Page

Resources

Page

Webinars

Page